Juliet Aaferemwin Yirerong, MD in Bridgeport, CT - Medicare Cardiovascular Disease (cardiology)

Juliet Aaferemwin Yirerong, MD is a medicare enrolled "Internal Medicine - Cardiovascular Disease" physician in Bridgeport, Connecticut. She graduated from medical school in 2012 and has 12 years of diverse experience with area of expertise as Cardiovascular Disease (cardiology). She is a member of the group practice Advanced Cardiovascular Specialists Pc and her current practice location is 439 Mill Hill Ave, Bridgeport, Connecticut. You can reach out to her office (for appointments etc.) via phone at (203) 334-2100.

Juliet Aaferemwin Yirerong is licensed to practice in Connecticut (license number 69396) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1043663826.

Contact Information

	Juliet Aaferemwin Yirerong, MD
	439 Mill Hill Ave, Bridgeport, CT 06610-2866
	(203) 334-2100
	(203) 333-5864

Physician's Profile

Full Name	Juliet Aaferemwin Yirerong
Gender	Female
Speciality	Cardiovascular Disease (cardiology)
Experience	12 Years
Location	439 Mill Hill Ave, Bridgeport, Connecticut
Accepts Medicare Assignments	Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Juliet Aaferemwin Yirerong graduated from medical school in 2012

NPI Data:

NPI Number: 1043663826
Provider Enumeration Date: 07/18/2016
Last Update Date: 08/05/2022

Medicare PECOS Information:

PECOS PAC ID: 4587959556
Enrollment ID: I20220817000608

Medical Identifiers

Medical identifiers for Juliet Aaferemwin Yirerong such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1043663826	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207R00000X	Internal Medicine	LP03799 (Rhode Island)	Secondary
207RC0000X	Internal Medicine - Cardiovascular Disease	69396 (Connecticut)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Bridgeport Hospital	Bridgeport, CT	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Advanced Cardiovascular Specialists Pc	4880678846	11

News Archive

Cannabidiol reduces cue-induced craving and anxiety in individuals with history of heroin abuse

Cannabidiol reduced cue-induced craving and anxiety in individuals with a history of heroin abuse, suggesting a potential role for it in helping to break the cycle of addiction, according to research conducted at the Icahn School of Medicine at Mount Sinai and published May 21 in the American Journal of Psychiatry.

Researchers discover new biomarker that puts patients at higher risk for metastasis of uveal melanoma

A study by J. William Harbour, M.D., associate director for Basic Research and leader of the Eye Cancer Site Disease Group at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, and colleagues published today in Clinical Cancer Research details the discovery of a biomarker that puts patients at a higher risk for metastasis of uveal melanoma.

Tianyin Pharmaceutical sales decrease 26.9% to $69.6 million for fiscal year 2012

Tianyin Pharmaceutical Inc., a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial results for the fiscal year 2012.

Funding neglected disease R&D beneficial to Europe, developing countries, report says

In this bulletin from Science Business, Karen Hoehn, vice executive director and director of international affairs at the German Foundation for World Population, highlights "a study by the independent research group Policy Cures, 'Saving Lives and Creating Impact: E.U. Investment in Poverty-Related and Neglected Disease.'"

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Juliet Aaferemwin Yirerong allows following entities to bill medicare on her behalf.

Entity Name	Advanced Cardiovascular Specialists Pc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1902957970 PECOS PAC ID: 4880678846 Enrollment ID: O20040616001064

News Archive

Cannabidiol reduces cue-induced craving and anxiety in individuals with history of heroin abuse

Researchers discover new biomarker that puts patients at higher risk for metastasis of uveal melanoma

Tianyin Pharmaceutical sales decrease 26.9% to $69.6 million for fiscal year 2012

Funding neglected disease R&D beneficial to Europe, developing countries, report says

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Juliet Aaferemwin Yirerong is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Juliet Aaferemwin Yirerong, MD 111 Brewster St, Pawtucket, RI 02860-4474 Ph: (401) 729-2258	Juliet Aaferemwin Yirerong, MD 439 Mill Hill Ave, Bridgeport, CT 06610-2866 Ph: (203) 334-2100

News Archive

Cannabidiol reduces cue-induced craving and anxiety in individuals with history of heroin abuse

Researchers discover new biomarker that puts patients at higher risk for metastasis of uveal melanoma

Tianyin Pharmaceutical sales decrease 26.9% to $69.6 million for fiscal year 2012

Funding neglected disease R&D beneficial to Europe, developing countries, report says

Internal Medicine Doctors in Bridgeport, CT

Mitchell Andrew Fogel, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 900 Madison Ave, Suite 209, Bridgeport, CT 06606 Phone: 203-335-0195 Fax: 203-335-7293
Christian Heineken, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 3180 Main St, Suite 301, Bridgeport, CT 06606 Phone: 203-373-9100 Fax: 203-365-8492
Pasquale Masone, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 3180 Main St, Suite 301, Bridgeport, CT 06606 Phone: 203-373-9100 Fax: 203-365-8492
Kevin B Panzer, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1381 Reservoir Ave., Bridgeport, CT 06606 Phone: 203-371-5197
Ms. Lucia Plichtova, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 267 Grant Street, Bridgeport, CT 06610 Phone: 203-384-3792
Hilda Daureen Kyotakoze, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 4920 Main St Fl 2, Bridgeport, CT 06606 Phone: 203-371-2986
Karen A Hutchinson, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 226 Mill Hill Ave, 3rd Floor, Bridgeport, CT 06610 Phone: 203-384-3873 Fax: 203-384-3829

Juliet Aaferemwin Yirerong, MD - Medicare Cardiovascular Disease (cardiology) in Bridgeport, CT

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Cannabidiol reduces cue-induced craving and anxiety in individuals with history of heroin abuse

Researchers discover new biomarker that puts patients at higher risk for metastasis of uveal melanoma

Tianyin Pharmaceutical sales decrease 26.9% to $69.6 million for fiscal year 2012

Funding neglected disease R&D beneficial to Europe, developing countries, report says

Medicare Reassignments

Cannabidiol reduces cue-induced craving and anxiety in individuals with history of heroin abuse

Researchers discover new biomarker that puts patients at higher risk for metastasis of uveal melanoma

Tianyin Pharmaceutical sales decrease 26.9% to $69.6 million for fiscal year 2012

Funding neglected disease R&D beneficial to Europe, developing countries, report says

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Cannabidiol reduces cue-induced craving and anxiety in individuals with history of heroin abuse

Researchers discover new biomarker that puts patients at higher risk for metastasis of uveal melanoma

Tianyin Pharmaceutical sales decrease 26.9% to $69.6 million for fiscal year 2012

Funding neglected disease R&D beneficial to Europe, developing countries, report says

Internal Medicine Doctors in Bridgeport, CT